LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 18.95 770.25 1480 1832 0.8076 0.6859
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 18.95 770.25 1922 1832 1.0488 1.0777
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 18.95 770.25 1908 1832 1.0412 1.0656
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 21.17 770.25 1563 2008 0.7782 0.6683
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 21.17 770.25 1998 2008 0.9948 0.9925
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 21.17 770.25 1973 2008 0.9824 0.9745
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 23.39 770.25 1618 2244 0.7209 0.6177
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 23.39 770.25 2092 2244 0.9321 0.9109
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 23.39 770.25 2032 2244 0.9053 0.8752
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 25.62 770.25 1712 2514 0.6808 0.5966
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 25.62 770.25 2210 2514 0.8788 0.8542
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 25.62 770.25 2091 2514 0.8315 0.7950
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 27.84 770.25 1813 2833 0.6398 0.5769
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 27.84 770.25 2328 2833 0.8215 0.8013
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 27.84 770.25 2241 2833 0.7908 0.7652
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 30.06 770.25 1924 3106 0.6194 0.5763
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 30.06 770.25 2427 3106 0.7814 0.7692
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 30.06 770.25 2372 3106 0.7637 0.7491
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 32.28 770.25 2047 3392 0.6033 0.5792
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 32.28 770.25 2546 3392 0.7504 0.7488
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 32.28 770.25 2478 3392 0.7304 0.7268
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 34.50 770.25 2112 3712 0.5690 0.5598
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 34.50 770.25 2728 3712 0.7349 0.7461
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 34.50 770.25 2608 3712 0.7026 0.7118
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 770.25 2264 4086 0.5541 0.5650
MN20160304_L02
G13